Author: Parkhomenko O.M.
The effectiveness of modern immunomodulatory and cardiometabolic therapy in correction the risk of hospital complications in patients with acute myocardial infarction with myocardial revascularization: the results of multifactorial analysisShumakov O.V. Dovgan О.V. Parkhomenko O.M. Talaeva T.V.... 1-2 (147-148) – I/IV 2022 24
Intravenous 5-lipoxygenase inhibitor quercetin prevents the development of intramyocardial hemorrhage in timely revascularized patients with STEMILutay Ya.M. Parkhomenko O.M. Yershovа O.B. 5(145) – IX/X 2021 15
